Immune cells that suppress genital herpes infections identified
The discovery of this subtype of immune cells, called CD8+ T cells, opens a new avenue of research to develop a vaccine to prevent and treat herpes simplex virus type 2, or HSV-2. Identifying these T cells’ specific molecular targets, called epitopes, is the next step in developing a vaccine. The findings are described in the May 8 advance online edition of Nature…